Skip to content
Search

Latest Stories

Sajid Javid shares agenda on healthcare reform; pharmacy bodies pledge support

The NHS is facing a range of long term challenges which needs to be countered with prevention, enhance personalized care and sustainable performance, health and social care secretary Sajid Javid said on Tuesday (March 8).

In his speech on healthcare reform at the Royal College of Physicians in London, he said: “We face some long-term challenges: how to keep the NHS focused on delivery while futureproofing it for changing demographics and disease; how to meet rising patient expectations and address the injustices of widespread disparities; and how to deal with an unsustainable financial trajectory while backing the brilliant people who work in health and care.”


Javid emphasized on three key points for healthcare reform – prevention, personalization and performance.

He said, prevention is not just about building a ‘national hospital service’ but a true ‘National Health Service’.

“The NHS spends vast sums treating people whose conditions are avoidable - and by some estimates 40 per cent of its costs go on treating preventable conditions.

“So I want us to shift to a new mode of operating – one that’s about helping the whole population to stay healthy, not just treating those who show up asking for help.”

He noted that primary care along with GPs, pharmacists and dentists must be at the heart of this new agenda on prevention.

The second point, personalization focuses on delivery of more personalised care, empowerment of patients and fulfilment of the technological leaps that was seen during the pandemic.

The third point, Performance emphasizes on ensuring the NHS delivers the British people the very best healthcare in the world.

THORRUN Thorrun Govind (Photo courtesy of RPS)

Welcoming Javid’s statement on recognizing pharmacists’ role at the heart of prevention, Royal Pharmaceutical Society England chair Thorrun Govind said: “Pharmacists working across the health service will be crucial to supporting the NHS recovery and how we transform services for the future.

“Medicines are the most common health intervention in the NHS and pharmacists will be central to supporting ambitions around personalized care, shared decision-making and ensuring best value for taxpayers.

“We also know that pharmacists will play a leading role personalized medicines and how we can identify and treat disease.

Govind said pharmacists can help manage growing demand on the NHS by supporting people with long-term conditions, but this must foster fresh thinking on service commissioning, including making the most of pharmacist independent prescribers.

She added that future reforms should “create the right incentives across primary and secondary care to drive integration and collaboration.”

“We also need to see sustained investment in the pharmacy workforce, supporting and upskilling existing staff and ensuring a pipeline of pharmacists for the future, as well as the accelerated roll-out of read-write access to patient records for pharmacists wherever they may work.”

Welcoming the secretary’s principles for healthcare reforms, Association of Independent Multiple Pharmacies chief executive Dr Leyla Hannbeck, said community pharmacy and all the staff working in it “are perfectly placed and trained to deliver them all.

“It’s an exciting and promising vision and community pharmacies are keen to be part of it. What we require now is the detail, what’s expected of us. We hope to be listened to and involved in the very early planning stages, not as in the past- just given sparse and ill thought through orders at the 11th hour.”

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less